NH Special Purpose Acquisition 30 Company (KOSDAQ:466910)
South Korea · Delayed Price · Currency is KRW 2,035.00
0.00 (0.00%)
At close: Aug 1, 2025, 3:30 PM KST
Ligand Pharmaceuticals Market Cap
KOSDAQ:466910 has a market cap or net worth of 18.47 billion as of August 8, 2025. Its market cap has increased by 1.00% in one year.
Market Cap
18.47B
Enterprise Value
n/a
Revenue
-110.88M
Ranking
n/a
PE Ratio
49.04
Stock Price
$2,035.00
Market Cap Chart
Since December 1, 2023, KOSDAQ:466910's market cap has decreased from 22.52B to 18.47B, a decrease of -17.98%. That is a compound annual growth rate of -11.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 18.47B | 4.37% |
| Dec 30, 2024 | 17.70B | 2.10% |
| Dec 28, 2023 | 17.34B | -23.03% |
| Dec 1, 2023 | 22.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 450.21T |
| SK hynix | 178.45T |
| LG Energy Solution | 89.86T |
| Samsung Biologics | 73.38T |
| Hanwha Aerospace | 48.16T |
| Hyundai Motor Company | 46.02T |
| Doosan Enerbility | 42.46T |
| KB Financial Group | 42.10T |